Call for Speakers: CHI’s Immunogenicity and Bioassay Summit 2015

CHI, organizer of the 7th Annual Immunogenicity and Bioasssay Summit 2015, has issued a call for papers for those who would like to present at its event on Nov. 17-19, 2015 in Baltimore, MD. Submission deadline is May 7, 2015.
 
NEEDHAM, Mass. - April 21, 2015 - PRLog -- CHI’s Seventh Annual Immunogenicity and Bioassay Summit 2015 will bring together over 250 directors, scientists and researchers from industry, FDA, and academia to discuss technologies and strategies for safe and efficacious products in the clinic.

CHI seeks high-quality papers related to the following topics:

• Regulatory expectations regarding immunogenicity assessment
• Case studies on meeting regulatory expectations with immunogenicity assessment
• Practical application of immunogenicity preclinical risk assessment
• Strategy for non-clinical ADA testing: How you interpret the results and understand the clinical relevance
• Different assay formats and technologies for immunogenicity assessment
• Experiences with neutralizing antibody (Nab) assays
• Interpretation and handling of drug interference
• Overcoming target interference in non-clinical studies
• Dealing with pre-existing positive ADA activity in study patients
• Critical issues in cut point determination and ADA assay validation
• Immunogenicity experiences with different products: MAbs, bispecifics, ADCs, peptides, etc.
• Clinical case studies on specific biotherapeutics
• Relationship between immunogenicity assay results and PK
• Immunogenicity assessment of biosimilars and non-innovator biologicals
• Risk factors that contribute to immunogenicity
• Tools and approaches for immunogenicity risk prediction
• Development of mouse models for predictive studies
• Impact of different routes of administration on immunogenicity
• Roles of sub-visible particles and aggregates in immunogenicity
• Impact of impurities on the immune response
• Deimmunization approaches
• Progress towards inducing immunological tolerance to biotherapeutics
• Focus on challenging therapeutic areas such as enzyme replacement therapy, anti-TNF and Factors VII and VIII
• Working with different assay types (Potency assays, Alpha screen assays, Fluorescence-based proximity assays, Octet assays, Reporter assays)
• Bioassays for cell and gene therapies
• Statistical design for assay development and validation
• Assay comparability case studies
• Characterization assays in support of characterization of antibody therapeutics
• Characterization and methods for ADCs and bispecifics
• Selecting the relevant method of action
• Method transfers to other groups or CROs
• Monitoring change and variability
• New technologies or formats for bioassays
• Expectations of health authorities

Follow this link to submit a speaker proposal:
http://www.immunogenicitysummit.com/immunogenicity-speaker-proposals/

Submission Deadline is May 5, 2015.

To inquire about sponsorship and exhibit opportunities, contact: Carolyn Benton, Tel: 781-972-5412, cbenton@healthtech.com.

About Cambridge Healthtech Institute (CHI)

Cambridge Healthtech Institute (CHI), founded in 1992, is the industry leader in providing superior-quality scientific information to eminent researchers and business experts from top pharmaceutical, biotech, and academic organizations. Delivering an assortment of resources such as events, reports, publications and eNewsletters, CHI's portfolio of products include Cambridge Healthtech Institute Conferences, Barnett Educational Services, Insight Pharma Reports, Cambridge Marketing Consultants, Cambridge Meeting Planners, Cambridge Healthtech Media Group, The Knowledge Foundation, and OpenHelix. http://www.chicorporate.com

Contact
James Prudhomme
***@healthtech.com
End
Source: » Follow
Email:***@healthtech.com Email Verified
Tags:Immunogenicity, Bioassay, Immunology, Assay, Biologicals
Industry:Medical, Science
Location:Needham - Massachusetts - United States
Account Email Address Verified     Account Phone Number Verified     Disclaimer     Report Abuse
Cambridge Healthtech Institute News
Trending
Most Viewed
Daily News



Like PRLog?
9K2K1K
Click to Share